Highly efficient in vitro and in vivo delivery of functional RNAs using new versatile MS2-chimeric retrovirus-like particles

Molecular Therapy Methods and Clinical Development

Volumn 2, Issue , 2015, Pages 15039-

  Prel, Anne ^a,b   Caval, Vincent ^a   Gayon, Régis ^c   Ravassard, Philippe ^d   Duthoit, Christine ^c   Payen, Emmanuel ^e   Maouche Chretien, Leila ^e   Creneguy, Alison ^f,g   Nguyen, Tuan Huy ^f,g   Martin, Nicolas ^c   Piver, Eric ^a,h   Sevrain, Raphaël ^c   Lamouroux, Lucille ^c   Leboulch, Philippe ^e   Deschaseaux, Frédéric ^b   Bouillé, Pascale ^c   Sensébé, Luc ^b   Pagès, Jean Christophe ^a,h  

^a UNIVERSITÉ DE TOURS   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c Parc Technologique du Canal 3   (France)

^d INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

^f NANTES UNIVERSITY HOSPITAL   (France)

^g UNIVERSITÉ DE NANTES   (France)

^h UNIVERSITY HOSPITAL OF TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; MESSENGER RNA; TRANSCRIPTION FACTOR DLX5; TRANSCRIPTION FACTOR RUNX2; VIRUS RNA; BONE MORPHOGENETIC PROTEIN 4; CD34 ANTIGEN; COAT PROTEIN; GENOMIC RNA; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; LORAZEPAM; NEOMYCIN; PUROMYCIN; RETROVIRUS VECTOR; RNA; TRANSCRIPTION FACTOR OSTERIX; TRANSFER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL DIFFERENTIATION; CELL FATE; CHIMERA; CONTROLLED STUDY; DIMERIZATION; FEMALE; GENE EXPRESSION; GENE LOCUS; HUMAN; HUMAN CELL; IN VITRO GENE TRANSFER; IN VIVO GENE TRANSFER; INDUCED PLURIPOTENT STEM CELL; LENTIVIRINAE; MALE; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; VIRAL GENE DELIVERY SYSTEM; VIRUS LIKE AGENT; ANIMAL MODEL; ENTEROBACTERIA PHAGE MS2; GENE TARGETING; IN VITRO STUDY; IN VIVO STUDY; LIVER; REPORTER GENE; RETROVIRIDAE; RNA TRANSPORT; VIRUS PARTICLE;

EID: 84978282650     PISSN: None     EISSN: 23290501     Source Type: Journal    
DOI: 10.1038/mtm.2015.39     Document Type: Article

References (59)

1. 1 Kaufmann, KB, Büning, H, Galy, A, Schambach, A, Grez, M, Gene therapy on the move. EMBO Mol Med 5 (2013), 1642–1661.
2. 2 Takahashi, K, Tanabe, K, Ohnuki, M, Narita, M, Ichisaka, T, Tomoda, K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007), 861–872.
3. 3 Yang, L, Yang, JL, Byrne, S, Pan, J, Church, GM, CRISPR/Cas9-directed genome editing of cultured cells. Curr Protoc Mol Biol 107 (2014), 31.1.1–31.1.17.
4. 4 Kuehle, J, Turan, S, Cantz, T, Hoffmann, D, Suerth, JD, Maetzig, T, et al. Modified lentiviral LTRs allow Flp recombinase-mediated cassette exchange and in vivo tracing of “factor-free” induced pluripotent stem cells. Mol Ther 22 (2014), 919–928.
5. 5 Cho, HJ, Lee, CS, Kwon, YW, Paek, JS, Lee, SH, Hur, J, et al. Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation. Blood 116 (2010), 386–395.
6. 6 Voelkel, C, Galla, M, Maetzig, T, Warlich, E, Kuehle, J, Zychlinski, D, et al. Protein transduction from retroviral Gag precursors. Proc Natl Acad Sci USA 107 (2010), 7805–7810.
7. 7 Green, AA, Silver, PA, Collins, JJ, Yin, P, Toehold switches: de-novo-designed regulators of gene expression. Cell 159 (2014), 925–939.
8. 8 D'Souza, V, Summers, MF, How retroviruses select their genomes. Nat Rev Microbiol 3 (2005), 643–655.
9. 9 Galla, M, Schambach, A, Towers, GJ, Baum, C, Cellular restriction of retrovirus particle-mediated mRNA transfer. J Virol 82 (2008), 3069–3077.
10. 10 Galla, M, Will, E, Kraunus, J, Chen, L, Baum, C, Retroviral pseudotransduction for targeted cell manipulation. Mol Cell 16 (2004), 309–315.
11. 11 Prel, A, Sensébé, L, Pagès, JC, Influence of untranslated regions on retroviral mRNA transfer and expression. BMC Biotechnol, 13, 2013, 35.
12. 12 Hamann, MV, Stanke, N, Müllers, E, Stirnnagel, K, Hütter, S, Artegiani, B, et al. Efficient transient genetic manipulation in vitro and in vivo by prototype foamy virus-mediated nonviral RNA transfer. Mol Ther 22 (2014), 1460–1471.
13. 13 Mock, U, Riecken, K, Berdien, B, Qasim, W, Chan, E, Cathomen, T, et al. Novel lentiviral vectors with mutated reverse transcriptase for mRNA delivery of TALE nucleases. Sci Rep, 4, 2014, 6409.
14. 14 Piver, E, Collin, C, Renault, N, Bru, T, Pagès, JC, Mobilization of full-length Semliki Forest virus replicon by retrovirus particles. J Virol 80 (2006), 9889–9895.
15. 15 Bertrand, E, Chartrand, P, Schaefer, M, Shenoy, SM, Singer, RH, Long, RM, Localization of ASH1 mRNA particles in living yeast. Mol Cell 2 (1998), 437–445.
16. 16 Poot, RA, Tsareva, NV, Boni, IV, van Duin, J, RNA folding kinetics regulates translation of phage MS2 maturation gene. Proc Natl Acad Sci USA 94 (1997), 10110–10115.
17. 17 van den Worm, SH, Stonehouse, NJ, Valegârd, K, Murray, JB, Walton, C, Fridborg, K, et al. Crystal structures of MS2 coat protein mutants in complex with wild-type RNA operator fragments. Nucleic Acids Res 26 (1998), 1345–1351.
18. 18 Querido, E, Chartrand, P, Using fluorescent proteins to study mRNA trafficking in living cells. Methods Cell Biol 85 (2008), 273–292.
19. 19 Yoon, JH, Srikantan, S, Gorospe, M, MS2-TRAP (MS2-tagged RNA affinity purification): tagging RNA to identify associated miRNAs. Methods 58 (2012), 81–87.
20. 20 Galaway, FA, Stockley, PG, MS2 viruslike particles: a robust, semisynthetic targeted drug delivery platform. Mol Pharm 10 (2013), 59–68.
21. 21 Pan, Y, Jia, T, Zhang, Y, Zhang, K, Zhang, R, Li, J, et al. MS2 VLP-based delivery of microRNA-146a inhibits autoantibody production in lupus-prone mice. Int J Nanomedicine 7 (2012), 5957–5967.
22. 22 Houzet, L, Morichaud, Z, Didierlaurent, L, Muriaux, D, Darlix, JL, Mougel, M, Nucleocapsid mutations turn HIV-1 into a DNA-containing virus. Nucleic Acids Res 36 (2008), 2311–2319.
23. 23 Kutluay, SB, Zang, T, Blanco-Melo, D, Powell, C, Jannain, D, Errando, M, et al. Global changes in the RNA binding specificity of HIV-1 gag regulate virion genesis. Cell 159 (2014), 1096–1109.
24. 24 Basyuk, E, Galli, T, Mougel, M, Blanchard, JM, Sitbon, M, Bertrand, E, Retroviral genomic RNAs are transported to the plasma membrane by endosomal vesicles. Dev Cell 5 (2003), 161–174.
25. 25 Jouvenet, N, Simon, SM, Bieniasz, PD, Imaging the interaction of HIV-1 genomes and Gag during assembly of individual viral particles. Proc Natl Acad Sci USA 106 (2009), 19114–19119.
26. 26 Dull, T, Zufferey, R, Kelly, M, Mandel, RJ, Nguyen, M, Trono, D, et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 72 (1998), 8463–8471.
27. 27 Muriaux, D, Darlix, JL, Properties and functions of the nucleocapsid protein in virus assembly. RNA Biol 7 (2010), 744–753.
28. 28 Dorange, F, Piver, E, Bru, T, Collin, C, Roingeard, P, Pagès, JC, Vesicular stomatitis virus glycoprotein: a transducing coat for SFV-based RNA vectors. J Gene Med 6 (2004), 1014–1022.
29. 29 Uchida, N, Hsieh, MM, Hayakawa, J, Madison, C, Washington, KN, Tisdale, JF, Optimal conditions for lentiviral transduction of engrafting human CD34+ cells. Gene Ther 18 (2011), 1078–1086.
30. 30 Schott, JW, Jaeschke, NM, Hoffmann, D, Maetzig, T, Ballmaier, M, Godinho, T, et al. Deciphering the impact of parameters influencing transgene expression kinetics after repeated cell transduction with integration-deficient retroviral vectors. Cytometry A 87 (2015), 405–418.
31. 31 Lohmann, V, HCV replicons: overview and basic protocols. Methods Mol Biol 510 (2009), 145–163.
32. 32 Srinivas, S, Watanabe, T, Lin, CS, William, CM, Tanabe, Y, Jessell, TM, et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol, 1, 2001, 4.
33. 33 Deschaseaux, F, Sensébé, L, Heymann, D, Mechanisms of bone repair and regeneration. Trends Mol Med 15 (2009), 417–429.
34. 34 Stewart, K, Walsh, S, Screen, J, Jefferiss, CM, Chainey, J, Jordan, GR, et al. Further characterization of cells expressing STRO-1 in cultures of adult human bone marrow stromal cells. J Bone Miner Res 14 (1999), 1345–1356.
35. 35 Sammons, J, Ahmed, N, El-Sheemy, M, Hassan, HT, The role of BMP-6, IL-6, and BMP-4 in mesenchymal stem cell-dependent bone development: effects on osteoblastic differentiation induced by parathyroid hormone and vitamin D(3). Stem Cells Dev 13 (2004), 273–280.
36. 36 Bouacida, A, Rosset, P, Trichet, V, Guilloton, F, Espagnolle, N, Cordonier, T, et al. Pericyte-like progenitors show high immaturity and engraftment potential as compared with mesenchymal stem cells. PLoS One, 7, 2012, e48648.
37. 37 Bianco, P, “Mesenchymal” stem cells. Annu Rev Cell Dev Biol 30 (2014), 677–704.
38. 38 Cordonnier, T, Layrolle, P, Gaillard, J, Langonné, A, Sensebé, L, Rosset, P, et al. 3D environment on human mesenchymal stem cells differentiation for bone tissue engineering. J Mater Sci Mater Med 21 (2010), 981–987.
39. 39 Lee, MH, Kim, YJ, Yoon, WJ, Kim, JI, Kim, BG, Hwang, YS, et al. Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter. J Biol Chem 280 (2005), 35579–35587.
40. 40 Chiellini, C, Grenningloh, G, Cochet, O, Scheideler, M, Trajanoski, Z, Ailhaud, G, et al. Stathmin-like 2, a developmentally-associated neuronal marker, is expressed and modulated during osteogenesis of human mesenchymal stem cells. Biochem Biophys Res Commun 374 (2008), 64–68.
41. 41 Galla, M, Schambach, A, Baum, C, Retrovirus-based mRNA transfer for transient cell manipulation. Methods Mol Biol 969 (2013), 139–161.
42. 42 Chick, HE, Nowrouzi, A, Fronza, R, McDonald, RA, Kane, NM, Alba, R, et al. Integrase-deficient lentiviral vectors mediate efficient gene transfer to human vascular smooth muscle cells with minimal genotoxic risk. Hum Gene Ther 23 (2012), 1247–1257.
43. 43 Yoshioka, N, Gros, E, Li, HR, Kumar, S, Deacon, DC, Maron, C, et al. Efficient generation of human iPSCs by a synthetic self-replicative RNA. Cell Stem Cell 13 (2013), 246–254.
44. 44 Singh, P, Schimenti, JC, Bolcun-Filas, E, A mouse geneticist's practical guide to CRISPR applications. Genetics 199 (2015), 1–15.
45. 45 Petsch, B, Schnee, M, Vogel, AB, Lange, E, Hoffmann, B, Voss, D, et al. Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection. Nat Biotechnol 30 (2012), 1210–1216.
46. 46 Brown, BD, Venneri, MA, Zingale, A, Sergi Sergi, L, Naldini, L, Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer. Nat Med 12 (2006), 585–591.
47. 47 Angel, M, Yanik, MF, Innate immune suppression enables frequent transfection with RNA encoding reprogramming proteins. PLoS One, 5, 2010, e11756.
48. 48 Flynn, RA, Chang, HY, Long noncoding RNAs in cell-fate programming and reprogramming. Cell Stem Cell 14 (2014), 752–761.
49. 49 Liu, Y, Cui, H, Wang, W, Li, L, Wang, Z, Yang, S, et al. Construction of circular miRNA sponges targeting miR-21 or miR-221 and demonstration of their excellent anticancer effects on malignant melanoma cells. Int J Biochem Cell Biol 45 (2013), 2643–2650.
50. 50 Feng, M, Jackson, WH Jr, Goldman, CK, Rancourt, C, Wang, M, Dusing, SK, et al. Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector. Nat Biotechnol 15 (1997), 866–870.
51. 51 Arruda, VR, Stedman, HH, Nichols, TC, Haskins, ME, Nicholson, M, Herzog, RW, et al. Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal model. Blood 105 (2005), 3458–3464.
52. 52 Toromanoff, A, Chérel, Y, Guilbaud, M, Penaud-Budloo, M, Snyder, RO, Haskins, ME, et al. Safety and efficacy of regional intravenous (r.i.) versus intramuscular (i.m.) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscle. Mol Ther 16 (2008), 1291–1299.
53. 53 Kanke, K, Masaki, H, Saito, T, Komiyama, Y, Hojo, H, Nakauchi, H, et al. Stepwise differentiation of pluripotent stem cells into osteoblasts using four small molecules under serum-free and feeder-free conditions. Stem Cell Reports 2 (2014), 751–760.
54. 54 Westerman, KA, Ao, Z, Cohen, EA, Leboulch, P, Design of a trans protease lentiviral packaging system that produces high titer virus. Retrovirology, 4, 2007, 96.
55. 55 Bloquel, C, Bejjani, R, Bigey, P, Bedioui, F, Doat, M, BenEzra, D, et al. Plasmid electrotransfer of eye ciliary muscle: principles and therapeutic efficacy using hTNF-alpha soluble receptor in uveitis. FASEB J 20 (2006), 389–391.
56. 56 Scharfmann, R, Xiao, X, Heimberg, H, Mallet, J, Ravassard, P, Beta cells within single human islets originate from multiple progenitors. PLoS One, 3, 2008, e3559.
57. 57 Saeed, AI, Sharov, V, White, J, Li, J, Liang, W, Bhagabati, N, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34 (2003), 374–378.
58. 58 Kamburov, A, Pentchev, K, Galicka, H, Wierling, C, Lehrach, H, Herwig, R, ConsensusPathDB: toward a more complete picture of cell biology. Nucleic Acids Res 39:Database issue (2011), D712–D717.
59. 59 Subramanian, A, Tamayo, P, Mootha, VK, Mukherjee, S, Ebert, BL, Gillette, MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102 (2005), 15545–15550.